Method for treating benign and malignant proliferative skin disease
US6087337A · kind A · utility
0Cited by
9References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 9, 1993 |
| Grant date | Jul 11, 2000 |
| Priority date | — |
| Expiry date | Jul 9, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating a mammal suffering from benign or malignant proliferative skin disease, e.g., melanoma or malignant skin metastases of melanoma, by topically administering to the mammal at the site of said diseased skin an effective amount of a somatostatin analog containing six or more amino acids.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.